Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Biotech firms are gaining major traction in 2025 due to the global pandemic. Take a look at some of the key features of biotech stocks before investing.

The industry of biotech is a great place to look for such stocks since so many of these companies are developing cutting-edge ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts By Adria Cimino – Jun 21, 2025 at 6:10PM ...

Oncolytics Biotech Inc shares N.ONCY are trading up $0.09 at $1.01.